Facial Hemiatrophy is a condition where one side of your face slowly shrinks or becomes smaller over time. It's a slow process that usually starts in childhood or young adulthood.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Facial Hemiatrophy?
Facial hemiatrophy, also called progressive hemifacial atrophy or Parry-Romberg syndrome, is a rare condition in which the tissue beneath the skin on one side of the face slowly wastes away. Fat, muscle, cartilage and sometimes bone can all shrink, so the cheek, the area around the eye, the jaw or the mouth on that side gradually looks hollow or sunken. The skin surface itself often looks fairly normal, while the tongue, gums and teeth on the affected side can also be involved. The condition matters for more than appearance. Some people develop headaches, seizures, eye problems or difficulty with chewing and their bite, and a visible change to the face can weigh heavily on confidence, especially in children and teenagers. Facial hemiatrophy is generally considered part of the localized scleroderma (morphea) family, a group of conditions that cause inflammation, scarring and tissue loss in the skin and the layers beneath it and, with rare exceptions, do not affect internal organs. It often overlaps with linear scleroderma en coup de sabre, a firm, shiny, sometimes darker groove on the forehead or scalp that can appear in the same person.
The cause is not known. The leading explanation is an autoimmune process, in which the immune system damages the body's own tissue, possibly through inflammation of small blood vessels and nerves on one side of the face. Supporting this, some people also have other autoimmune conditions such as thyroid disease or vitiligo, and antinuclear antibodies (ANA), a blood marker often seen in autoimmune disease, are found in roughly a quarter to half of people tested. An earlier injury to the face or head, infections and a disturbance of the nerves that control blood flow have all been suggested as contributors, but none has been proven. The condition usually begins in childhood or the teenage years, although it can start in adulthood, and it is more common in females than males. It is not considered an inherited condition, and cases within the same family are rare.
There is no single test for facial hemiatrophy. Diagnosis rests mainly on the pattern a clinician sees: gradual tissue loss on one side of the face without another explanation, often with little change to the skin surface. A dermatologist or rheumatologist usually leads the assessment, and experts recommend that children be referred to a specialized pediatric rheumatology center. A skin biopsy is not always needed but may help when the picture is unclear or the skin becomes firm. Blood tests are often normal apart from a positive ANA, so they support the diagnosis rather than settle it. Because the condition can reach deeper structures, the workup looks beyond the face. Expert recommendations call for a magnetic resonance imaging (MRI) scan of the head at diagnosis when the face or scalp is involved, even without neurological symptoms, because brain changes can be present without causing problems. An EEG (a recording of the brain's electrical activity) is used if seizures are suspected. An eye examination that includes screening for uveitis (inflammation inside the eye, which often causes no symptoms) and a dental, orthodontic and jaw assessment are recommended at diagnosis and during follow-up. Serial photographs, and sometimes specialized ultrasound, help show whether the condition is still active.
Treatment has two separate goals: stopping the disease while it is active, and restoring the face once it has settled. Because the condition is rare, most of the evidence comes from case series and expert consensus rather than large trials. For active, worsening disease, the usual first choice is methotrexate, a medicine that lowers the activity of the immune system and is taken once a week as a tablet or injection. It works slowly, so a corticosteroid such as prednisone by mouth, or high-dose methylprednisolone given into a vein, is often added for the first few months as a bridge. When methotrexate helps, it is generally continued for at least 12 months after improvement before being tapered, because shorter courses are often followed by relapse. It aims to halt further loss and cannot replace tissue that is already gone. Common side effects include nausea and temporary changes in liver tests. Methotrexate can harm a developing baby, so it must not be used during pregnancy and is stopped before trying to become pregnant, which makes pregnancy plans part of choosing it. Mycophenolate mofetil, another immune-suppressing medicine, is an option when methotrexate does not work or is not tolerated. It also harms a developing baby, raising the risk of miscarriage and birth defects, so the same pregnancy planning applies. Reconstructive surgery addresses lost volume and asymmetry. Fat grafting (moving a person's own fat by injection) or fillers can treat mild to moderate hollowing, while more severe loss may need tissue flaps, bone grafts or implants, often over several procedures. Most specialists prefer to wait until the condition has stopped progressing so that results are not undone by further loss, although some favor earlier surgery for young people because of the emotional and social toll. Orthodontic treatment can help guide jaw growth in the meantime. Seizures, headaches and eye problems are treated in their own right by the relevant specialists.
Facial hemiatrophy usually progresses slowly for several years and then stops on its own. It often settles within about 2 to 10 years, although some people have active disease for longer, and a minority notice it speeding up again after a quiet period. In one large survey of people with the condition, some linked worsening to pregnancy, the months after childbirth or stressful periods, but those reports could not be confirmed. Tissue that has been lost does not grow back by itself, so the asymmetry that remains depends largely on how extensive the disease was before it settled. Daily life is shaped by how much of the face is affected and which structures are involved. Some people have only mild hollowing; others have changes to the jaw, teeth, bite or eye that affect chewing, speech or vision. Headaches are common and can begin at any point in the course. Regular follow-up with the treating specialist, along with periodic eye and dental reviews, helps catch new activity or complications early. The visible difference can affect confidence and relationships, and bullying is a recognized problem for children, so psychological support is a reasonable part of care.
See a doctor if one side of the face seems to be gradually thinning or sinking, or a firm, shiny band appears on the forehead or scalp, especially in a child. Assessment while the disease is still active gives treatment the best chance of limiting further loss. For someone already diagnosed, contact the care team if the face starts changing again after a quiet period, or if new headaches, facial pain or numbness, jaw problems, or changes in behavior or learning appear. Vision changes, eye pain or redness, or an eye that looks newly sunken call for prompt contact with the care team and an eye examination. A first seizure, or any seizure lasting more than five minutes, is an emergency: call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Facial Hemiatrophy is like, what's helped you, or ask the community a question.